Researcher Profile Statistics: Louka, M.
Geo Map
Region
#
AS - Asia, other
8
AF - Africa
4
EU - Europe
2
NA - North America
2
Unknown
20
Total
36
Country
#
CN - China
8
EG - Egypt
4
US - United States of America
2
DE - Germany
1
MD - Moldova
1
Unknown
20
Total
36
City
#
Al Fayyum
2
Nanjing
2
Cairo
1
Chengdu
1
Chisinau
1
Clifton
1
Guangzhou
1
Mountain View
1
Wenzhou
1
Unknown
25
Total
36
Most viewed items
#
ID: 353 - Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia
36
Total
36
Most type viewed
#
ID: all -
36
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
36
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
0 0 0 0
0 3
3
2020
4 3
0 0 0 0
0 0 0 0
0 1
8
2021
0 0
1 0 0 0
0 1 1 0
0 0
3
2022
1 0
1 0 1 0
0 0 0 3
0 0
6
2023
0 0
1 1 0 0
0 1 0 0
0 4
7
2024
1 0
3 0 1 0
0 0 1 0
0 0
6
Ever
36
Geo Map
Region | # |
---|---|
AS - Asia, other | 8 |
AF - Africa | 4 |
EU - Europe | 2 |
NA - North America | 2 |
Unknown | 20 |
Total | 36 |
Country | # |
---|---|
CN - China | 8 |
EG - Egypt | 4 |
US - United States of America | 2 |
DE - Germany | 1 |
MD - Moldova | 1 |
Unknown | 20 |
Total | 36 |
City | # |
---|---|
Al Fayyum | 2 |
Nanjing | 2 |
Cairo | 1 |
Chengdu | 1 |
Chisinau | 1 |
Clifton | 1 |
Guangzhou | 1 |
Mountain View | 1 |
Wenzhou | 1 |
Unknown | 25 |
Total | 36 |
Most viewed items | # |
---|---|
ID: 353 - Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia | 36 |
Total | 36 |
Most type viewed | # |
---|---|
ID: all - | 36 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 36 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
2020 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 8 |
2021 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 3 |
2022 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 6 |
2023 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 7 |
2024 | 1 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6 |
Ever | 36 |